NEW YORK (Reuters Health) – In patients with extensively drug-resistant tuberculosis (XDR TB), adding a later-generation fluoroquinolone to the treatment regimen may improve outcomes, even when drug-susceptibility testing…
NEW YORK (Reuters Health) – Across many subgroups of preterm infants, high-frequency oscillatory ventilation (HFOV) and conventional ventilation are just as likely to prevent bronchopulmonary dysplasia, and they…
NEW YORK (Reuters Health) – Starting antibiotics within the first two days of hospitalization for chronic obstructive pulmonary disease (COPD) significantly improved outcomes in a large cohort study…
NEW YORK (Reuters Health) – Beta-blockers can improve survival and reduce exacerbations of chronic obstructive pulmonary disease (COPD) – even in patients with cardiovascular disease, a new study…
NEW YORK (Reuters Health) – In preterm infants born at a gestational age of 32 weeks or younger, keeping oxygen saturation low in the first few weeks of…
NEW YORK (Reuters Health) – Giving a single antenatal course of intramuscular corticosteroids after 34 weeks of gestation significantly enhances fetal lung maturity in pregnancies with documented fetal…
NEW YORK (Reuters Health) – In mice, treating primary respiratory syncytial virus (RSV) with the cysteinyl leukotriene 1 receptor antagonist montelukast reduces airway hyperresponsiveness and inflammation after RSV…
NEW YORK (Reuters Health) – Adding inhaled treprostinil (Tyvaso) to oral bosentan for pulmonary arterial hypertension (PAH) improves exercise capacity and quality of life, according to a report…
NEW YORK (Reuters Health) – The nonselective beta-blocker carvedilol and the beta-1-selective beta-blockers metoprolol succinate and bisoprolol have significantly different treatment effects in patients with chronic heart failure…
NEW YORK (Reuters Health) – When should cystic fibrosis patients with hemoptysis or pneumothorax be hospitalized? When should they receive antibiotics? When should a chest tube be placed…